Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.43 |
| ▸ | MYC | P01106 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31026219 | 1.00 | CYP3A4 (0.52) | CYP3A4ACHECA12CA1CA2 | |
| SCHEMBL25669658 | 0.88 | CA12 (0.50) | CYP3A4ACHECA12CA1CA2 | |
| Methyl 3,5-Dihydroxybenzoate SCHEMBL29467415 | 0.83 | CA12 (0.62) | CYP3A4ACHECA12CA1CA2 | |
| SCHEMBL89590 | 0.82 | CYP3A4 (0.52) | CYP3A4ACHECA12CA1CA2 | |
| SCHEMBL2317959 | 0.82 | CSNK2A1 (0.57) | ACHECA12CA1CA2CA7 | |
| SCHEMBL3361120 | 0.78 | AKR1C3 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6262459 | 0.78 | KDM4E (0.68) | CYP3A4ACHECA12CA1CA2 | |
| SCHEMBL21609786 | 0.78 | AKR1C4 (0.44) | CYP3A4ACHECA12CA1CA2 | |
| SCHEMBL15864848 | 0.78 | CA1 (0.53) | CYP3A4CA1CA2ALDH1A1TSHR | |
| SCHEMBL9039800 | 0.78 | KDM4E (0.68) | CYP3A4ALDH1A1PTGS2TSHRCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5908723-A | Recording sheets | XEROX CORPORATION (US) | 1999-06-01 | — | — | US | claimed |
| EP-0083886-B1 | ORGANIC COMPOUND OF THE TRIPLE SUBSTITUTED BIPHENYLYL BENZOATE TYPE AND PROCESS FOR ITS PREPARATION | THOMSON-CSF (FR) | 1985-05-22 | — | — | EP | claimed |
| US-12473249-B2 | Aromatic compounds and pharmaceutical uses thereof | BASF AS (NO) | 2025-11-18 | — | — | US | disclosed |
| CN-114318626-A | Fabric | 东丽纤维研究所（中国）有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20210380521-A1 | AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | BASF AS (NO) | 2021-12-09 | — | — | US | disclosed |
| US-20210380521-A1 | AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | BASF AS (NO) | 2021-12-09 | — | — | US | disclosed |
| US-11129781-B2 | Agent for hair deforming treatment | KAO CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| US-11129902-B2 | Enhanced SN-38 anticancer agent | Alhamadsheh, Mamoun M. (US) | 2021-09-28 | — | — | US | disclosed |
| EP-3179857-B1 | CONJUGATION OF PHARMACEUTICALLY ACTIVE AGENTS WITH TRANSTHYRETIN LIGANDS THROUGH ADJUSTABLE LINKERS TO INCREASE SERUM HALF-LIFE | ALHAMADSHEH MAMOUN M (US) | 2021-09-08 | — | — | EP | disclosed |
| EP-3864001-A1 | ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | BASF AS (NO) | 2021-08-18 | — | — | EP | disclosed |
| CN-113166024-A | Aromatic compounds and their medical use | 巴斯夫股份公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-1993021259-A1 | DENDRITIC BASED MACROMOLECULES AND METHOD OF PRODUCTION | CORNELL RESEARCH FOUNDATION INC. (US) | 1993-10-28 | — | — | WO | disclosed |
| US-5225522-A | Multiply-branched aliphatic-aromatic polyesters and method for preparing multiply-branched aliphatic-aromatic polyesters | EASTMAN KODAK COMPANY (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0535192-A1 | NOVEL DNA GYRASE INHIBITORS, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME. | HOFFMANN LA ROCHE (CH) | 1993-04-07 | — | — | EP | disclosed |
| WO-1993002038-A1 | ESTER COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1993-02-04 | — | — | WO | disclosed |
| WO-1992018490-A1 | NOVEL DNA GYRASE INHIBITORS, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME | F. HOFFMANN-LA ROCHE AG (CH) | 1992-10-29 | — | — | WO | disclosed |
| US-4788083-A | POLYURETHANES, POT LIFE | ASHLAND OIL, INC. (US) | 1988-11-29 | — | — | US | disclosed |
| US-4627928-A | Basic non-carbonated magnesium compositions and fuel, lubricant and additive concentrate compositions containing same | THE LUBRIZOL CORPORATION (US) | 1986-12-09 | — | — | US | disclosed |
| US-4474679-A | DISPLAY DEVICES | THOMSON-CSF (FR) | 1984-10-02 | — | — | US | disclosed |
| US-4337169-A | Process for producing microcapsules | MITSUBISHI PAPER MILLS, LTD. (JP) | 1982-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12473249-B2 | Aromatic compounds and pharmaceutical uses thereof | GLS2, FFAR3, SLC10A1 | CYP3A4 132/4885ACHE 2035/4885CA12 1054/4885 |
| US-20210380521-A1 | AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | GLS2, FFAR3, SLC10A1 | CYP3A4 132/4885ACHE 2035/4885CA12 1054/4885 |
| US-11129902-B2 | Enhanced SN-38 anticancer agent | LENG8, TSG101, CD47 | CYP3A4 3651/4885ACHE 2127/4885CA12 1249/4885 |
| US-11129781-B2 | Agent for hair deforming treatment | GRHPR, SLC26A4, COL1A1 | CYP3A4 3291/4885ACHE 4677/4885CA12 1628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.